Revenue Operations Analyst
Share role
The recipient sees their own assessment. Your profile and score are not shared.
About the role
H1 seeks a Revenue Operations Analyst for its India-remote Sales Operations team. The role supports deal desk workflows, CRM governance, revenue planning, dashboards, commercial performance analysis, AI-enabled RevOps workflows, and operational improvement. Applicants need 2–4 years in Sales Strategy, Revenue Operations, or Go-to-Market Operations, plus process, tooling, analytical, and communication skills. An in-person final interview is required and may involve travel.
Key requirements
- • At least 2 years of relevant experience
- • Required skills: Sales Strategy, Revenue Operations, or Go-to-Market Operations, Designing, improving, and operationalizing business processes at scale, Salesforce, CPQ tools, and other go-to-market tools, AI assistants, including development of skills/workflows and dashboards, Advanced proficiency in Excel or Google Sheets, Strong analytical skills, Cross-functional communication and presentation of data and recommendations
Opportunity details
- • Workplace: Remote
- • Posted: Oct 8, 2026
- • Original advert language: English
Full vacancy
HealthRoleIQ regularly verifies this opportunity against the employer’s posting and highlights the details relevant to your match.
See original vacancy ↗Employer’s role description
Job title: Revenue Operations Analyst
Department: Sales Operations
Team: Sales Operations
Location: India Remote
All locations: India Remote
Work type: Full time
Workplace type: remote
At H1, we believe access to the best healthcare information is a basic human right. Our mission is to provide a platform that can optimally inform every doctor interaction globally. This promotes health equity and builds needed trust in healthcare systems. To accomplish this our teams harness the power of data and AI-technology to unlock groundbreaking medical insights and convert those insights into action that result in optimal patient outcomes and accelerates an equitable and inclusive drug development lifecycle.